0001567619-18-006089.txt : 20181114
0001567619-18-006089.hdr.sgml : 20181114
20181114120950
ACCESSION NUMBER: 0001567619-18-006089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181112
FILED AS OF DATE: 20181114
DATE AS OF CHANGE: 20181114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hartman Thomas E
CENTRAL INDEX KEY: 0001466989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 181181854
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2018-11-12
0
0000722723
HANGER, INC.
HNGR
0001466989
Hartman Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP and General Counsel
Common Stock
2018-11-12
4
F
0
302
20.03
D
62408
D
Common Stock
2018-11-12
4
S
0
2200
20.2632
D
60208
D
Common Stock
2018-11-13
4
S
0
3800
19.6732
D
56408
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
70818
70818
D
Performance Share Units
2020-05-19
Common Stock
28327
28327
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
These shares were sold at a range of sale prices from $20.00 to $20.5365. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares were sold at a range of sale prices from $19.50 to $19.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of (i) unvested restricted shares and fully vested shares totaling 9,860 shares of stock from an initial grant of 10,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; (ii) unvested restricted shares totaling 11,147 shares of stock from an initial grant of 11,147 shares of restricted stock that begins to vest on March 9, 2019; (iii) unvested restricted shares and fully vested shares totaling 5,042 shares of stock from an initial grant of 6,359 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 6, 2018 and 2019; (iv) unvested restricted shares and fully vested shares totaling 9,391 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 8, 2018; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 4,353 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (vi) unvested restricted shares and fully vested shares totaling 6,911 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; (vii) unvested restricted shares and fully vested shares totaling 3,977 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (viii) unvested restricted shares and fully vested shares totaling 2,885 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(ix) fully vested shares totaling 764 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014 (x) fully vested shares totaling 878 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; and (xi) fully vested shares totaling 1,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman
2018-11-14